Quick Answer
Ovid Therapeutics Inc. reported Common Stock Shares Outstanding of 130.18 million shares for the year ending 2025.
- Ovid Therapeutics Inc. showed an increase of +83.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Ovid Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Ovid Therapeutics Inc.'s Common Stock Shares Outstanding has grown by 1,223.2%.
- Historical annual values: Fiscal year 2025: 130.18 million shares | Fiscal year 2024: 71.01 million shares | Fiscal year 2023: 70.69 million shares | Fiscal year 2022: 70.47 million shares | Fiscal year 2021: 70.36 million shares | Fiscal year 2020: 65.74 million shares | Fiscal year 2019: 54.71 million shares | Fiscal year 2018: 24.65 million shares | Fiscal year 2017: 24.61 million shares | Fiscal year 2016: 9.84 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: